Prev Arrow Stocks

Aramark ($ARMK) Stock Forecast: Up 5.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Aramark?

ARMK is the ticker symbol for Aramark, a company primarily operating in food services, which recently reported strong second-quarter fiscal 2026 results. The company has seen a bullish movement in its stock price today.

Why is Aramark going up?

ARMK stock is up 5.1% on May 13, 2026 19:42

  • Aramark's partnership with the University of Wisconsin–Oshkosh to enhance dining options and campus life likely boosted investor confidence in the company's growth prospects.
  • The increase in Aramark's 12-month price target by analysts, implying a 7% upside, may have attracted more investors to the stock.
  • Exceeding fiscal Q2 revenue expectations and raising its fiscal 2026 outlook, especially with the launch of Aramark Nexus™ targeting the AI data center market, contributed to the bullish movement in ARMK stock.
  • Despite the view of Aramark's shares as overvalued, the positive financial performance and strategic initiatives seem to have outweighed this concern in today's market activity.

ARMK Price Chart

ARMK Technical Analysis

ARMK News

New UW–Oshkosh food plan brings athlete fuel, allergen-safe menus, app ordering

Aramark has partnered with the University of Wisconsin–Oshkosh to implement a new dining and hospitality program. This initiative includes features like an "Eat to Excel" retail location for athletes, expanded retail options with virtual dining, and a True Balance station for allergen-safe meals. The program aims to enhance campus life, offer diverse food choices, and support the university's growth and recruitment goals.

https://www.stocktitan.net/news/ARMK/aramark-and-university-of-wisconsin-oshkosh-partner-to-elevate-the-rb4owvf0e4dn.html

0 News Article Image New UW–Oshkosh food plan brings athlete fuel, allergen-safe menus, app ordering

Aramark Stock 12‑Month Price Target Raised to $51.93, Implies 7% Upside

Aramark's (ARMK) average 12-month price target has been increased to $51.93 from $51.57 by 14 analysts, with forecasts ranging from $47 to $58. This updated target suggests a 7% potential upside based on the closing price of May 12. The consensus rating for Aramark remains a "Buy" from 17 analysts, comprising 13 Buys, 3 Holds, and 1 Sell.

https://www.tradingview.com/news/tradingview:a5082f9262f03:0-aramark-stock-12-month-price-target-raised-to-51-43-implies-6-upside/

1 News Article Image Aramark Stock 12‑Month Price Target Raised to $51.93, Implies 7% Upside

Raising Aramark's Fair Value Estimate on Guidance Increase, but Shares Remain Overvalued

Morningstar has raised its fair value estimate for Aramark (ARMK) following an increase in the company's financial guidance. Despite the increased estimate, Morningstar analysts still consider Aramark's shares to be overvalued. The company operates primarily in food services, with a significant portion of its operating profit derived from the United States.

https://www.morningstar.com/company-reports/1481698-raising-aramarks-fair-value-estimate-on-guidance-increase-but-shares-remain-overvalued

2 News Article Image Raising Aramark's Fair Value Estimate on Guidance Increase, but Shares Remain Overvalued

GameStop, Hims & Hers Health slide premarket; Aramark rises

U.S. stock futures opened lower due to Middle East tensions and upcoming inflation data. GameStop slumped after eBay rejected its takeover bid, while Hims & Hers Health also fell due to disappointing Q1 revenue and a surprise loss. Conversely, Aramark shares rose after exceeding fiscal Q2 revenue expectations.

https://www.investing.com/news/stock-market-news/gamestop-hims--hers-health-slide-premarket--aramark-rises-4680037

3 Missing News Article Image GameStop, Hims & Hers Health slide premarket; Aramark rises

Aramark (NYSE: ARMK) boosts 2026 outlook after strong Q2

Aramark (NYSE: ARMK) reported strong second-quarter fiscal 2026 results, with revenue rising to $4.91 billion and diluted EPS increasing to $0.38. The company raised its fiscal 2026 organic revenue growth outlook to the high end of 7%-9% and affirmed growth targets for Adjusted Operating Income and Adjusted EPS. Additionally, Aramark launched Aramark Nexus™, a new platform targeting the hyperscale AI data center market, and announced a quarterly dividend of $0.12 per share.

https://www.stocktitan.net/sec-filings/ARMK/8-k-aramark-reports-material-event-64f26cb62250.html

4 News Article Image Aramark (NYSE: ARMK) boosts 2026 outlook after strong Q2

Aramark Price History

17.10.2025 - ARMK Stock was up 3.7%

  • Aramark's stock price surged despite the company posting a fourth-quarter fiscal 2025 earnings miss, with revenue growth falling short of analyst consensus estimates.
  • The market may have reacted positively due to the company's revenue growth of 14% year-on-year on both GAAP and organic bases, indicating underlying strength in its business operations.
  • Investors might be optimistic about Aramark's future prospects, overlooking the current earnings and revenue surprises, as analysts had higher expectations for the company's performance.
  • The bullish movement could also be attributed to broader market trends and positive sentiment, as U.S. stock futures were trading higher on the day.

12.04.2026 - ARMK Stock was up 10.2%

  • ARMK reported robust second-quarter fiscal 2026 results, with revenue and diluted EPS exceeding expectations, leading to an optimistic outlook for the year.
  • Despite the positive financial performance, news of layoffs at the University of Kentucky raised concerns about the company's operational changes and potential legal implications.
  • The launch of Aramark Nexus™ targeting the hyperscale AI data center market showcases the company's diversification efforts and innovation, contributing to investor confidence.
  • The market's bullish response may be attributed to the company's strategic initiatives and financial performance outweighing concerns related to the University of Kentucky contract termination and associated layoffs.

11.01.2026 - ARMK Stock was up 5.0%

  • Aramark (ARMK) showed a strong bullish movement following its Q1 earnings report, exceeding expectations and demonstrating solid revenue growth.
  • Improved profit margins, strong contract retention, and notable new client acquisitions were key factors in the positive market sentiment.
  • Although there are concerns regarding a thin net profit margin and challenges related to interest coverage and labor exposure, Aramark's reaffirmed full-year outlook and strategic capital allocation plans have boosted investor confidence.
  • The company's impressive financial performance, surpassing analyst forecasts, and ability to show resilience in challenging times are driving investor optimism and lifting the stock price.

12.01.2026 - ARMK Stock was down 7.3%

  • Several financial institutions adjusted Aramark's price target to $47, suggesting optimism and potential growth.
  • Despite surpassing fiscal Q1 2026 earnings expectations with notable achievements in client retention and new business acquisition, the stock faced a downward trend.
  • The uncertainty surrounding renewing the contract with Springfield Public Schools Board may have raised concerns about future revenue, affecting investor confidence.
  • The decrease in the stock value could be due to investors selling to lock in profits after recent price target revisions and positive performance news related to Aramark.

05.00.2026 - ARMK Stock was up 3.5%

  • ARMK's assumption of food service operations at the University at Albany, featuring unconventional dining spaces and a wide range of food choices, is believed to have positively influenced market sentiment towards the company.
  • Despite falling short of sales projections in Q3 CY2025, Aramark's strategic maneuvers, including a $1.34 million investment from Pacer Advisors Inc. and heightened stake from other entities, have fostered investor confidence.
  • Upgraded revenue forecasts for the full fiscal year and better-than-anticipated EPS guidance for fiscal year 2026 have positioned Aramark for future expansion, countering the impact of its recent sales performance.
  • Overall, the bullish market shift towards ARMK reflects the company's strategic efforts, optimistic investor attitudes, and growth potential despite temporary operational challenges.

10.01.2026 - ARMK Stock was up 4.7%

  • Aramark's stock experienced a strong bullish movement today, likely propelled by positive market sentiment and excitement over the company's upcoming Q1 2026 earnings.
  • Despite previous revenue challenges and industry underperformance, analysts are upbeat about Aramark's revenue growth and adjusted earnings in the current quarter, potentially driving the stock's upward trajectory.
  • The company's recognition as one of Fortune's Most Admired Companies for 2026 may have further bolstered investor faith in Aramark's future outlook and operational capabilities.
  • Nevertheless, concerns voiced by DePaul University students regarding on-campus dining choices might affect Aramark's reputation and customer satisfaction in the future, underscoring the importance of monitoring feedback and making operational enhancements.

13.04.2026 - ARMK Stock was up 5.1%

  • Aramark's partnership with the University of Wisconsin–Oshkosh to enhance dining options and campus life likely boosted investor confidence in the company's growth prospects.
  • The increase in Aramark's 12-month price target by analysts, implying a 7% upside, may have attracted more investors to the stock.
  • Exceeding fiscal Q2 revenue expectations and raising its fiscal 2026 outlook, especially with the launch of Aramark Nexus™ targeting the AI data center market, contributed to the bullish movement in ARMK stock.
  • Despite the view of Aramark's shares as overvalued, the positive financial performance and strategic initiatives seem to have outweighed this concern in today's market activity.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.